HIF1A and neoplasm: Iron depletion therapy must be carefully managed to avoid inducing hypoxia and subsequent upregulation of hypoxia‐inducible factor 1‐alpha (HIF‐1α), which can promote chemoresistance and tumor recurrence in glioblastoma (GBM).